Sitryx

Sitryx is a biopharmaceutical company focused on developing disease-modifying therapies for autoimmune and inflammatory diseases by targeting immunometabolism. Their research is based on the understanding that metabolic pathways play a crucial role in regulating immune cell function and activation, and that dysregulation in these pathways contributes to the progression of chronic inflammatory diseases. Sitryx aims to develop first- and best-in-class therapies that rebalance the immune system and achieve disease remission, leading to better patient outcomes.

The company boasts a strong team of experienced drug hunters and developers, supported by world-class academic founders and top-tier board members. Sitryx has secured significant funding, including a Series A financing round of $30 million and a global licensing and research collaboration with Eli Lilly. They are headquartered in Oxford, UK, and have a growing pipeline of projects at various stages of drug discovery, focused on atopic dermatitis, pulmonary fibrosis, ulcerative colitis, and other autoimmune indications.

Sitryx offers a semi-virtual work environment, allowing for flexible working arrangements. The majority of the team works from their purpose-built laboratories at Oxford Science Park, but the company leverages a strong network of supporting national and international CROs, collaborators and consultants, enabling access to additional expertise and resources as needed.

Sitryx is a biopharmaceutical company pioneering the field of immunometabolism to develop innovative disease-modifying therapeutics for chronic autoimmune and inflammatory diseases. By targeting metabolic pathways that regulate immune cell function, Sitryx aims to rebalance the immune system and achieve disease remission, leading to improved patient outcomes. Their commitment to groundbreaking science and a highly experienced team positions Sitryx as a leader in the development of transformative therapies to address a broad range of debilitating diseases with unmet medical need.

Sitryx promotes a collaborative and transparent culture, emphasizing the importance of teamwork, open communication, and a shared passion for scientific innovation. They value the input of all team members, encouraging a culture of learning and growth, where bold science and a focus on unmet patient needs are prioritized. The company embraces flexibility and adaptability, working with a network of collaborators and consultants to ensure access to the best expertise and resources.

Sitryx promotes a culture of diversity, equity, and inclusion by valuing the unique contributions of all team members. They believe in building an inclusive environment where everyone feels welcome, respected, and empowered to succeed. Sitryx recognizes the importance of a diverse workforce and actively seeks to attract and retain talented individuals from a range of backgrounds, perspectives, and experiences. Their commitment to DEI is reflected in their values and practices, fostering a collaborative and supportive environment where every voice is heard and valued.